Recent studies have reported a higher abundance of Bifidobacterium in the tissues of patients with colorectal adenomas [42, 43] and advanced pancreatic cancer in mice [44], whereas other studies have reported that Bifidobacterium correlates with an increased anti-PD-L1 therapeutic response [45, 46]. The gene discussed is CD274; the disease is familial pancreatic carcinoma.